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Increased tobacco smoke exposure positively correlates with
a wide variety of cancers including those of lung, breast,
pancreas, and prostate cancer. There are about 250chemicals
present in tobacco that have been linked to cancer. Smokeless
tobacco, in the form of chewed tobacco leaves, snuﬀ,a n d
betel quid, has also been linked to oral and pancreatic
cancers. Recent eﬀorts to decipher mechanisms by which
tobacco-derived carcinogens induce various cancers have
provided profound insights about signaling pathways that
are perturbed by these compounds, leading to oncogenic
signaling. This special issue collates reviews and research
articles that provide insights about tobacco-induced cancers
at molecular, clinical, and epidemiological level.
Emphasizing the use of tobacco as a global health
concern, Oppeltz et al. provide a detailed review highlighting
the trend towards increased tobacco use and the increasing
cancer burden in developing countries. Developing coun-
tries, such as Taiwan, may indeed be at risk which is
underscored by the study of Lin et al., who evaluated a
prospective study cohort and found that habitual cigarette
smokers, alcohol consumers, and betel quid chewers have a
higher risk of contracting oral cancer. This study ﬁnds an
alarming40-foldriskofdevelopingoralcancerinindividuals
who have all the above habits than controls.
The risk of cancer is not limited to smokers but also
aﬀects individuals who are indirectly exposed to tobacco-
derived carcinogens. However, the link between paternal
smoking and childhood leukemia is not yet clearly estab-
lished. Using meta-analysis, an interesting review article
by Liu et al. draws a link between paternal smoking and
childhood acute lymphoblastic leukemia. Pancreatic cancers
have been linked to tobacco use. A research article by Lochan
et al. further implicates family history as an important factor
promoting cancers among smokers. The authors ﬁnd that
individuals with a family history of malignancy are at an
increased risk of pancreatic cancer. Furthermore, individuals
with a family history of malignancy and who smoke appear
to require a lesser degree of tobacco exposure for the
developmentofpancreaticcancer.Tocurbtheuseoftobacco,
it is necessary to provide professional smoking cessation aid.
However, smoking cessation intervention should be tailored
depending on the population and ethnicity, and behavioral
and cultural diﬀerences should be taken into account. A
study by Delnevo et al. indicates the heterogeneous nature of
tobacco use among South Asian immigrants in the USA. The
study drives an important point of segregating tobacco users
depending on their country of origin, and not just grouping
them as “Asians,” for a more reliable understanding into the
behavior of tobacco use in this population. A short clinical
report by Mazza et al. emphasizes the need for smoking
cessation clinics in comprehensive cancer centres to beneﬁt
smoker cancer patients.
Understandingtobacco-inducedcancersatthemolecular
level is key for developing biomarkers and therapeutics for
early intervention. Chen et al. provide a comprehensive2 Journal of Oncology
review about epigenetic and molecular mechanisms that are
deregulated by tobacco carcinogens with special emphasis on
nicotine, N-nitrosodiethylamine, 4-(methylnitrosamino)-1-
(3-pyridyl)-1-butanone (NNK), and polyaromatic hydrocar-
bon. This paper highlights the complex nature of tobacco-
induced carcinogenesis and provides recent updates on
molecular targets which include receptors, cell cycle regula-
tors,mitogen-activatedproteinkinases,apoptosis mediators,
angiogenic factors, and invasion and metastasis mediators.
A research article by Dev et al. explores the molecular
mechanism of cigarette-smoke—induced proliferation of
lung cells. They found that p-benzoquinone, in aqueous
smoke extract, binds and modiﬁes EGFR, preventing its
degradation leading to increased EGFR signaling and prolif-
eration. Chaudhry et al., on the other hand, report the eﬀects
of brief exposure to tobacco-derived carcinogens, including
NNK, on cellular activity, morphology, and gene expression
of bronchial epithelial cells. Knowledge gained from in vitro
work has been extended to in vivo models. Recent advances
in transgenic and knockout animal models have provided
unprecedented opportunity to selectively perturb molecular
pathways and understand its role in tobacco-induced car-
cinogenesis. Zheng et al. provide a comprehensive review
of our current understanding of pathways altered by NNKs
using such animal models.
Search for reliable biomarkers for early detection of lung
and oral cancer is an active area of research. Recent advances
in tools to probe epigenetic changes in the DNA have
included DNA methylation in the repertoire of biomarkers
of predictive and prognostic importance. Using MethyLight
assays, Salskov et al. investigated hypermethylation in lung
tissues in a cohort of smokers and nonsmokers for nine-
teen gene promoters. Their data suggests hypermethylation
of CCND2 could reﬂect smoking-induced precancerous
changes in the lung. Although several compounds in tobacco
are proven carcinogens, nicotine, the main addictive com-
pound in tobacco, is not carcinogenic. Two review articles,
one by Singh et al. and the other by Lee et al., describe the
role of nicotine in carcinogenesis. While Singh et al. examine
the historical data connecting nicotine tumor progression
with updates on recent eﬀorts to target the nicotinic acetyl-
choline receptors to combat cancer, Lee et al. provide recent
updates on the assembly, activity, and biological functions
of nicotinic receptors, with current understanding regarding
developments in the therapeutic application of nicotinic
receptor ligands. Carcinogens present in cigarette smoke
are not always intrinsic to tobacco leaves; fertilizer-derived
carcinogens and microbial toxins could also contribute to
carcinogenesis. Review articles by Zaga et al. about radioac-
tive carcinogens, Pb-210 and Po-210, which accumulate in
tobacco leaves, and by Pauly et al. about microbes and
microbial toxins in cigarettes, provide important insight into
the interesting cancer-promoting milieu of tobacco smoke.
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